Linezolid was introduced by the World Health Organization (WHO) in 2022, as part of the BPaLM regimen, also comprising ...

The Gujarat government reported a significant reduction in tuberculosis cases and mortality rates in 2023, credited to ...

The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...

Current treatment for bedaquiline-resistant tuberculosis is linked with poor microbiological responses, unfavorable clinical ...

Tuberculosis (TB) is a bacterial infection. It most commonly causes a lung infection after a period of no disease activity, with symptoms such as coughing, chest pain, and fatigue. In some cases ...

Compared to 2015, Gujarat saw a 34% reduction in new TB cases and a 37% decline in the mortality rate in 2023. For this achievement, the Government of India has awarded Gujarat the first rank in the ...

Tuberculosis has passed Covid as the top infectious disease killer, despite new medicines and better diagnostic tools. ... The only TB vaccine in use today was first given to people in 1921; ...

The 2024 Global Tuberculosis Report, published last week by the World Health Organization, puts TB back in the top slot with 1.25 million deaths in 2023 compared to 320,000 COVID-19 deaths.

For the last 100 years, we’ve only had one TB vaccine — and it leaves a lot to be desired. Skip to main content. ... This ancient disease, known today as tuberculosis or TB, ...

ISLAMABAD - The Global Fund has cut $27 million from Pakistan's health funding, significantly affecting national programs ...

How money is helping people avoid and fight TB. Tuberculosis is famously a disease of poverty. People are exposed to the bacteria that causes TB in overcrowded, under ventilated spaces.